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Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Polydrug Use in Adolescence 
Marta Rodríguez-Arias and María Asunción Aguilar 
University of Valencia 
Spain 
1. Introduction 
1.1 Drug and polydrug use among adolescents 
The 2010 Monitoring the Future survey conducted by the US government raises concerns 
about an increase in drug use among teenagers, particularly those of a younger age. A 
similar trend has been reflected by European surveys, such as the 2010 Annual report on the 
state of the drugs problem in Europe, EMCDDA. According to this study, commissioned by 
the European Council, the use of multiple substances — polydrug use — is widespread and 
represents a major challenge. A recent survey by the Spanish government (EDADES 
2009/2010) revealed that approximately 50% of drug users consumed two or more 
substances simultaneously. The objective of users is to increase or reverse the effects of the 
different drugs taken, but greater health risks and problems and a poor treatment response 
are also inherent in polydrug consumption. Almost all patterns of polydrug use include 
alcohol, and the use of amphetamines or ecstasy among frequent or heavy alcohol 
consumers is much higher than the average. A study by the Spanish government (Encuesta 
Estatal sobre uso de drogas en estudiantes de enseñanzas secundarias, ESTUDES, 2008) 
revealed that Spanish students between 14-18 years old who used drugs generally 
consumed more than one drug at the same time. 96.2% of students who had taken ecstasy in 
the previous year had simultaneously consumed alcohol and 86.1% had simultaneously 
consumed cannabis. An association between consumption of stimulants and hallucinogen 
drugs was also reported. For example, among students who had used ecstasy in the 
previous year, 71.4% had also consumed cocaine, while 38.5% of those who had used 
cocaine in the same period had also consumed ecstasy.  
2. The adolescent brain 
Adolescence is the period of gradual physiological, cognitive, behavioural and psychosocial 
transition from childhood to adulthood (Pickles et al., 1998) during which individuals 
experience physical changes, new interests, greater independence and heightened 
responsibility.  Since adolescence is a process, it is difficult to characterize its ontogenetic 
time course, and no single event signals its onset or termination. In humans, adolescence is 
often considered to begin with the onset of the biological changes associated with puberty 
(the period during which an individual becomes sexually mature), although the timing of 
puberty within the adolescent period varies notably among humans. Adolescence ends 
when the individual assumes adult social roles, with a change in the sleep pattern having 
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been proposed as a physiological marker of its termination (Abbott, 2005). The adolescent 
age span in humans is commonly considered to be from 12 to 18 years, although the entire 
second decade is sometimes considered adolescence, with up to 25 years being considered 
late adolescence (Baumrind, 1987).  
Adolescent subjects exhibit certain characteristic behaviours (some of which are common 
among adolescents across species), including hyperphagia, shorter periods of sleep, 
increases in peer-directed social interactions and affiliation with peers, an increase in the 
number of conflicts with parents, egocentrism, a lack of ‘common sense’ in decision-making, 
rigidity in reasoning, impulsivity, including a preference for actions that offer immediate 
rewards (cognitive impulsivity), reduced self-control, enhanced novelty-seeking and risk-
taking behaviours (Spear, 2011a; Sturman & Moghaddam, 2011). All of these behaviours can 
lead to a higher incidence of risky behaviours such as misconduct at school, drink driving, 
unsafe sex, use of illegal drugs, and antisocial behaviours (Doremus-Fitzwater et al., 2010; 
Eaton et al., 2010; Spear, 2011b). Although cognitive control improves throughout 
adolescence (Luna et al., 2010), youths show differences in cognitive strategies in relation to 
adults. According to the “fuzzy trace theory” adolescents process the risk and benefits of 
choices more explicitly than adults, which, paradoxically, leads to greater risk-taking (Rivers 
et al., 2008). The characteristic irresponsibility of adolescents may be due to differences in 
the way in which they experience risk and reward, especially under conditions of 
heightened emotional arousal (Sturman & Moghaddam, 2011). Thus, the risk-taking 
behaviour of adolescents is probably related to the fact that their decision-making capacity 
is more vulnerable to disruption by stress. Adolescence is generally considered to be a 
stressful stage of life, and individuals are more likely to perceive events as stressful at this 
age, with adolescents exhibiting higher rates of depressed mood, sleep problems, emotional 
instability, anxiety and self-consciousness (Buchanan et al., 1992). Moreover, some aspects of 
neurobehavioural and hormonal responses to stressors also vary when adolescents are 
compared to younger or older individuals (Allen & Matthews, 1997). Similarly, behavioural 
experiments in laboratory animals have revealed that adolescents are more disrupted by 
stressors than younger or older counterparts and that they differ behaviourally and 
physiologically in their response to stressors when compared to animals of other ages 
(Buwalda et al., 2011; Stone & Quartermain, 1998; Vázquez, 1998). For example, the rise in 
plasma corticosterone levels induced by restraint stress is prolonged in adolescent rats in 
comparison with adult animals. Moreover, while adult male rats, which are repeatedly 
exposed to daily restraint stress, show a clear habituation in their neuroendocrine response, 
adolescent male rats actually exhibit a facilitation of this response (Romeo, 2010). 
The characteristic behaviour of adolescence can be explained in neurobiological terms 
(Brenhouse & Andersen, 2011; Casey et al., 2011; Sturman & Moghaddam, 2011). Indeed, the 
features of an adolescent brain predispose individuals to behaving in the way referred to 
above. Maturational alterations of the brain contribute to these age-specific behavioural 
characteristics, including the increase in risk-taking and propensity to use drugs of abuse 
(Doremus-Fitzwater et al., 2010). Recent research has demonstrated the importance of 
gonadal hormones for neurobehavioural maturation during adolescence in laboratory 
animals and an association between gonadal hormones and adolescent behaviour/mood in 
humans (see Vigil et al., 2011, for review). Adolescence represents a stage of development of 
the nervous system (as does embryonic development) in which steroid hormones trigger 
various organizational phenomena related to structural brain circuit remodelling: 
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myelination, apoptosis, neural pruning, and dendritic spine remodelling, thus determining 
the adult behavioural response to steroids or sensory stimuli (Vigil et al., 2011).  
The adolescent brain undergoes dramatic changes in gross morphology. During this phase 
there is a massive loss of gray matter and synapses in neocortical brain regions (Gogtay et 
al., 2004), and the most characteristic ontogenetic change, which occurs across a variety of 
species, is an alteration of the prefrontal cortex. Throughout human adolescence there is a 
marked increase in hemispheric asymmetry and in the degree to which the two cerebral 
hemispheres can process information independently (Merola & Liederman, 1985). In the 
primate cortex, the density of receptors of different neurotransmitter systems (dopamine, 
serotonine, acetylcholine, and GABA) decreases as adolescence progresses (Lidow et al., 
1991; Brenhouse & Andersen, 2011). Most of the synapses that undergo pruning during 
adolescence are excitatory, which results in a decline in N-methyl-D-aspartate (NMDA) 
receptors and the extension of glutaminergic excitatory stimulation to the cortex (Insel et al., 
1990). There is a body of evidence to show that the balance of excitatory and inhibitory 
neurotransmission varies between adolescents and adults, suggesting that the increased 
inhibition associated with development of the prefrontal cortex promotes greater neural 
coordination (Sturman & Moghaddam, 2011). 
Maturational changes are also evident during adolescence in limbic regions such as the 
hippocampus (Insel et al., 1990; Wolfer and Lipp, 1995), and gray matter reductions also take 
place in the striatum and other subcortical structures (Sowell et al., 2002). Conversely, white 
matter increases in cortical and subcortical fiber tracts (Paus et al., 2001) and in circuits 
connecting the amygdala and striatum with the prefrontal cortex (Asato et al 2010). A decrease 
is observed in glutamate receptors in the hippocampus (Insel et al., 1990) and DA receptors in 
the striatum (Seeman et al., 1987; Teicher et al, 1995). Cannabinoid binding peaks in the limbic 
forebrain of rats during adolescence before declining to adult levels (Rodriguez de Fonseca et 
al., 1993). Experimental evidence supports a shift during adolescence from a relative balance 
between subcortical and cortical DA systems toward a greater predominance of cortical DA. In 
contrast to this enhanced DA tone in the prefrontal cortex during adolescence, DA activity in 
the accumbens and other subcortical DA terminal regions seems to be less noticeable in 
adolescents than in adults (Andersen & Gazzara, 1993). Basal levels of synaptic DA are lower 
during this phase of development, although adolescents show a greater and faster increase in 
drug-induced DA release (Badanich et al. 2006; Laviola et al. 2001). Consistent with this, 
adolescents are generally subject to a less positive impact from stimuli with moderate to low 
incentive value, and thus seek additional appetitive reinforcers (Spear, 2000).  
Neuroimaging studies have shown variations in human adolescent functional activity in 
different forebrain regions, including the amygdala, orbitofrontal cortex and striatum (Bjork 
et al., 2010). For example, the amygdala and accumbens of adolescents exhibit more activity 
than those of adults (Ernst et al., 2002). Similarly, in comparison to adults, adolescents show 
a lower response to reward in the lateral orbitofrontal cortex and a higher activity in the 
nucleus accumbens (Galvan et al., 2006). Neural coordination within and between brain 
regions as well as processing efficiency are reduced in adolescents due to a less-effective 
information transfer between regions, incomplete myelination, and imbalances in neuronal 
inhibition/excitation within critical brain regions (Sturman & Moghaddan, 2011). Human 
and animal studies have revealed a differential development of subcortical limbic systems 
related to top-down control systems during adolescent brain development, with subcortical 
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limbic systems developing earlier than control systems. It has been proposed that the 
mechanisms underlying adolescent changes in behaviour (impulsiveness, risky choices, 
drug taking, etc.) could underlie an imbalance between an increased sensitivity to 
motivational cues and immature cognitive control (Casey et al., 2011). In summary, 
immature neuronal processing in the prefrontal cortex and other cortical and subcortical 
regions, and their interaction, lead to a behaviour that is biased toward risk and emotional 
reactivity during the adolescent period (Sturman & Moghaddan, 2011). 
 
Fig. 1. Neural circuit involved in motivated behaviour. Thick lines represent hyperactive 
brain areas or connections and faint and dashed lines represent brain areas that are more 
hypoactive in adolescent subjects than in adults. 
The adolescent brain operates in a promotivational state due to the combination of three 
factors: 
a. limited inhibitory capacity and poor regulatory control (due to the lack of cortical 
maturation)  
b. DA hyperactivity in the nucleus accumbens when processing appetitive stimuli 
c. Amygdala hyperactivity, which explains affective intensity and liability, and a weaker 
harm-avoidance system (Ernst et al., 2009). 
The relatively early development of bottom-up limbic regions (nucleus accumbens and 
amygdala), along with an immaturity of top-down regulatory systems (PFC), biases behavior 
toward risk-taking, risk-seeking, impulsive choice, sensation-seeking and novelty preference. 
3. Effects of drugs on adolescents 
In addition to increases in sensation- and novelty-seeking, drug use is more common during 
adolescence (2010 Annual report on the state of the drugs problem in Europe, EMCDDA; 
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Doremus-Fitzwater et al., 2010; Spear, 2011b). Youngsters differ from adults in their 
response to a variety of drugs (Schramm-Sapyta et al., 2009). These ontogenetic variations in 
drug responsiveness may be related with age differences in pharmacokinetics, particularly 
with respect to the functioning of the neural substrates upon which these drugs act, and also 
with social enhancement. As discussed previously, the neural systems involved in the 
effects exerted by drugs (mesolimbic DA system) differ considerably between adolescents 
and adults. These ontogenetic differences in drug responsiveness may have significant 
consequences for adolescents, who exhibit a reduced sensitivity to various drugs of abuse. 
This insensitivity can promote greater use per occasion in relation to more mature 
individuals (Schramm-Sapyta et al., 2009). After peer substance use, the next most powerful 
predictor of adolescent alcohol and drug use is perceived stress (Wagner et al., 1999). In 
animal models, stress has been shown to increase the rewarding effects of drugs of abuse 
(Piazza & LeMoal, 1998; Ribeiro Do Couto et al., 2006). On the other hand, experimental data 
suggest that drugs of abuse induce stronger effects in adolescents than in adults, although 
the literature is not conclusive regarding these differences (for review see Schramm-Sapyta 
et al., 2009). The developmental stage of adolescence can promote early experimentation 
with drugs, as addictive substances are generally more rewarding and less aversive 
(Schramm-Sapyta et al., 2009).  
Moreover, adolescent substance use disrupts the normal development of an adolescent 
brain. Exposure to drugs of abuse can induce neurobehavioural, neurochemical and 
neuroendocrinal effects in the adolescent rat brain, thereby affecting the growth process and 
systems involved in plasticity and cognition (Jain & Balhara, 2010). Since adolescents 
undergo structural and functional dynamic changes in brain areas implicated in the 
reinforcing properties of drugs of abuse (prefrontal cortex and ventral striatum) and habit 
formation (dorsal striatum), drug-taking during this period could increase susceptibility to 
drug dependence, although there is a lack of studies that demonstrate causality.  
4. Animal models of drug addiction 
The use of animal models to study drug addiction has the advantage of experimental control 
of variables (age of initial exposure, drug, dose, duration, timing of exposure, etc.) and has 
provided much valuable information. The main drawback to animal studies is that no 
model completely reproduces all the stages in the development of drug addiction. Results 
obtained with multiple behavioural and neurobiological models are necessary to achieve a 
deeper understanding of this disorder (Ahmed, 2010; Belin et al. 2010; Sanchis-Segura & 
Spanagel, 2006; Schramm-Sapyta et al., 2009; Shippenberg & Koob, 2002; Weiss, 2010). 
There are several animal models with a high predictive value, though most studies are 
performed with one of two paradigms: self-administration or conditioned place preference 
(CPP) (Aguilar et al., 2009). The most direct procedure for evaluating the reinforcing 
properties of a substance is self-administration (the animal works to obtain the substance: 
for example by pressing a lever), which assesses the intrinsic rewarding properties of a 
substance; and both oral and intravenous routes have been used to assess the relevance of 
age in voluntary intake. Animals that acquire drug-taking behaviour more quickly or 
indulge in it more frequently can be considered to resemble human drug addicts. However, 
drug taking, even when acquired quickly, is not equivalent to drug dependence (Ahmed, 
2010). Another shortcoming of the self-administration paradigm is the complexity of the 
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technique and the lack of a standardized procedure for evaluating substances with different 
potencies, reinforcement properties and pharmacokinetics. The choice of training substance, 
species and procedural parameters can radically affect the results obtained (Moser et al., 
2011). Variations of the self-administration model have been developed to study the main 
features of addiction. For example, the progressive ratio method designed by Hodos (1961), 
in which the sweetness and volume of a milk is varied in order to measure reward strength, 
has been used to assess motivation to seek a drug (Depoortere et al., 1993). On the other 
hand, extinction and reinstatement paradigms are employed to model relapse. Following  
acquisition of self-administration, animals undergo a process by which the response is 
extinguished and reinstatement is induced by drug priming, stress or drug-associated cues 
(Shaham et al., 2003; Epstein et al., 2006). Time-out and punished responding model 
compulsive use (Deroche-Gamonet et al., 2004; Vanderschuren and Everitt, 2004) and long-
access training schedules model high-level use (Knackstedt & Kalivas, 2007). Additionally, 
models of habitual drug-seeking have also been developed (Everitt et al., 2008). 
The CPP paradigm (in which rodents repeatedly exposed to a distinct environment in the 
presence of a positively reinforcing substance show preference for that environment) 
evaluates the conditioned rewarding properties of a substance, and is also frequently used 
due to its procedural simplicity and rapidity. This model is dose-sensitive, and drugs of 
abuse are typically rewarding at low to moderate doses and aversive at high doses. CPP is 
sensitive to a wide range of substances. In general, CPP is useful for measuring the level and 
persistence of drug-induced reward (Tzschentke, 1998), but not for modelling pathological 
drug-seeking or taking. For this reason, variations of this procedure (adding an extinction 
and reinstatement of the extinguished conditioned preference) have been developed to 
model addiction-like behaviours (Aguilar et al., 2009).  
Other animal models are employed to study motor behaviour, conditioned aversion, 
withdrawal, sensitization and compulsive drug-seeking (Belin et al., 2009; Schramm-Sapyta 
et al., 2009; Weiss, 2010). Most drugs of abuse stimulate locomotor behaviour through 
activation of the dopaminergic circuits that contribute to their reinforcing effects. At lower 
doses locomotor activity is generally increased, whereas at higher doses, locomotion falls 
and stereotypical behaviour can emerge. Conditioned place and taste aversion are designed 
to assess the aversive effects of drugs of abuse (which are assumed to discourage intake). 
Animals are trained to associate a place or a palatable flavour with the aversive sensations 
induced by a drug injected by the experimenter (generally lithium), which causes the place 
or flavour to be subsequently avoided. These tests measure the use-limiting effects of drugs 
of abuse but do not model pathological drug-seeking or taking (Schramm-Sapyta et al., 
2009), since experimenter-delivered injections greatly differ from volitional intake even for 
the aversive effects of the drug (Galici et al., 2000).  
Withdrawal is a constellation of affective and physiological changes that occurs after 
cessation of intake of some drugs of abuse and is used to evaluate dependence. Symptoms 
generally reflect the reversal of initial drug effects, although they vary with the drug, 
duration and extent of exposure. This, together with the kind of observations made and the 
choice of end points, can obstruct the interpretation of withdrawal effects (Moser et al., 
2011). In the case of ethanol or opioids, withdrawal effects (including autonomic and 
behavioural activation) can be easily quantified in animal models. Withdrawal from 
psychostimulants and most other drugs of abuse results in a generalized “negative 
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motivational state” which can be assessed using an intracranial self-stimulation procedure 
(Bauzo & Bruijnzeel, 2012) or an anxiety-like state which can be assessed using many 
models, including the social interaction test and elevated plus maze (Hall et al. 2010). 
Repeated exposure to any of the aforementioned drugs can lead to a phenomenon called 
sensitization, in which the ambulatory, stereotypic or rewarding effect of a repeated low 
dose is augmented. Sensitization reflects lasting neuroplastic changes in response to 
repeated exposure, and is hypothesized to be a behavioural correlate of increased drug 
craving and development of dependence (Robinson and Berridge, 2008), though its 
relevance to drug dependence is debatable. However, since data from sensitization studies 
have led to the development of pharmacotherapies that have been tested in animal models 
of relapse and in human addicts, some authors support sensitisation as a useful model for 
determining the neural basis of addiction (Steketee & Kalivas, 2011). Compulsive drug-
seeking is analysed by the more complex methods of self-administration (progressive ratio, 
extinction, reinstatement, punishment, long-access, etc.), which tend to be more informative 
regarding vulnerability to addiction. However, it is difficult to employ these new techniques 
in developmental studies that aim to examine the behaviour of adolescent vs adult rodents, 
partly due to the prolonged duration of the experimental procedures. 
5. Animal models of adolescent polydrug consumption 
Recent advances in imaging have made it easier to study the human brain, but many 
questions about the effect of drugs in the adolescent brain require experimental 
manipulation in experimental animals in order to be answered. Given the across-species 
similarities in neurobehavioural features of adolescence, non-human animals undergoing 
this developmental transition can be used as models of human adolescence (Spear, 2000). 
There is growing evidence that adolescent humans and rodents experience many similar 
structural and functional changes in the brain as they progress towards adulthood. 
Behavioural changes characteristics of adolescence (increased social behaviour, novelty- and 
sensation-seeking, risk-taking, emotional instability and impulsivity) are also observed in 
rodents (Jain & Balhara, 2010). However, the use of adolescent rodent models does have 
some limitations. There are numerous areas of adolescent functioning in humans that cannot 
be addressed using animal models (peer pressure and self esteem, impact of parenting 
styles, obsession about weight, etc.). Moreover, the increases in adrenal 
hormones/neuroactive steroids during adrenarche in humans are generally not evident in 
other mammalian species. Furthermore, forebrain systems of rodents are less prominent 
than in humans, their social organization is simpler, and the time course of adolescence is 
briefer. The time frame of adolescence in non-human animals such as the rat is even more 
difficult to characterize than in humans. Among researchers who study adolescence in rats, 
opinions differ somewhat (Spear, 2000). The problem is further magnified by the limited 
amount of research to have focused on adolescence in laboratory animals. Animals of both 
genders exhibit neurobehavioural characteristics typical of adolescence during the period 
between postnatal days 28 and 42. According to hormonal, physical and social criteria, this 
development phase corresponds with age 12-18 in humans (Spear 2000). Moreover, different 
physiological changes (growth spurt, loss of excitatory input to prefrontal cortex, vaginal 
opening in females and increases in maturing spermatids in males) occur during this period. 
Indeed, some ontogenetic changes that signal the early onset of adolescence in female rats 
can emerge as early as 20 days of age, with later development taking place up until 55-60 
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days of age in males. Taking into account the abovementioned limitations, adolescent rodent 
models can be considered to possess good face and construct validity, since there are strong 
similarities between human adolescents and various animal models of adolescence in terms 
of developmental history, behavioural traits and neural and hormonal characteristics (Spear, 
2011a). As more information is generated, stronger evidence of these forms of validity, and 
of predictive validity, will no doubt be obtained.  
Moreover, there are several methodological difficulties that are encountered when using 
experimental animals to model the complex pattern of drug abuse observed in humans. A 
polydrug animal model of drug abuse allows a situation that is closer to reality than the simple 
effect produced by one drug. However, a number of variables need to be taken into account 
when using such a model. Comparison of the studies published in the literature is difficult, 
since practically each one of them represents a different model of polydrug administration. 
This is to be expected given the high number of variables involved in this kind of study 
(Schensul et al., 2005). The first variable to bear in mind is the combination of drugs employed. 
In most studies only two drugs are employed; in many cases cocaine or alcohol. Another 
important aspect is the temporal pattern of drug administration employed. Until now, most 
studies have focused on acute administration (Braida & Sala, 2002; Daza-Losada et al., 2009a; 
Diller et al., 2007; Manzanedo et al., 2010; Robledo et al., 2007), though there is a growing 
number of studies employing repeated administration and studying long-term effects (Achat-
Mendes et al., 2003; Daza-Losada et al., 2008a, 2008b, 2009; Estelles et al., 2006; Jones et al., 
2010; Ribeiro Do Couto et al., 2011a, 2011b; Rodriguez-Arias et al., 2011). This is another point 
of discrepancy; some studies have measured effects after very short periods post-
administration (only 2 or 3 days), while others have assessed effects weeks or even months 
after the last administration. Finally, the effect under evaluation can vary considerably 
between purely physiological studies and those focusing exclusively on behavioural changes. 
All these discrepancies point to the fact that polydrug models simplify the complex reality of 
human consumption, in which each the pattern of drug use of each individual is unique.  
Most of the studies that have assessed polydrug use have employed adult animals and acute 
administration. Thus, it is necessary to design models of adolescent polydrug consumption 
that reflect the human reality, despite the intrinsic difficulties they may pose. Our research 
group has been working for several years in this field during which we have studied 
different drug combinations and different patterns of drug administration.  
The aim of the present chapter is to offer a detailed review of the experiments performed in 
this area. With this purpose in mind we will discuss not only the key results obtained in our 
experiments but also those of other studies of adolescent polydrug use. In an attempt to 
provide a clear overview of the evidence obtained to date, studies have been classified 
according to the pattern of drug administration employed. In this way, studies employing 
acute administration of drugs and studying immediate effects have been grouped together. 
Studies evaluating the binge pattern of drug administration, commonly employed by users 
of psychostimulants, constitute a second group. This section also represents a recently 
employed model developed with the aim of replicating the binge drinking that is so 
common among adolescents and young people of many cultures. Finally, we will discuss 
several studies in which a specific drug has triggered the reinstatement of drug-seeking 
behaviour of a different pharmacological kind of drug, known as the cross-reinstatement 
phenomenon and also the phenomenon of sensitization. 
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6. Principal results 
6.1 Acute polydrug studies 
6.1.1 MDMA plus cocaine 
Preclinical studies have until now focused mainly on the long-term consequences of drug 
pre-treatment in terms of subsequent changes in spontaneous behaviour or in the response 
to other drugs of abuse. For instance, a substantial number of studies have focused on the 
long-term consequences of MDMA pre-treatment on subsequent cocaine administration 
(Achat-Mendes et al., 2003; Åberg et al., 2007; Daza-Losada et al., 2008, 2009b). However, 
hardly any have examined the interactive profile of concomitant exposure to MDMA and 
cocaine. Diller and coworkers (2007) studied the effects of concurrent administration of 
MDMA and cocaine on CPP in adult rats, finding that both drugs induced CPP when 
administered alone. Co-administration, on the other hand, produced an antagonism, except 
when higher doses were employed. These results highlight how the neurochemical and 
behavioural effects of MDMA and cocaine consumed separately are dramatically altered 
when taken together. Based on the inverse relation between serotonin and DA activity (in 
general, decreases in serotonin neurotransmission produce an increase of DA function) (Di 
Giovanni et al., 2010), these authors speculated that cocaine had undermined MDMA-
mediated serotonin release more than MDMA-mediated DA release, thereby increasing the 
overall reward. 
In a more recent study, we focused on the interaction of acute MDMA and cocaine 
administration in adolescent mice (Daza-Losada et al., 2009a), studying the acute interaction 
of both drugs on motor activity, anxiety, memory and brain monoamines. One of the most 
important results of this study was that acutely administered cocaine plus MDMA induced 
an anxiolytic response in the elevated plus maze that was not present when the drugs were 
administered separately. Mice treated with cocaine and MDMA spent significantly more 
time in the open arms of the plus maze than controls or animals treated with just one of the 
drugs. This result was not due to an unspecific increase of motor activity, as no increase in 
the number of total or closed entries was observed in animals treated with both drugs. 
Although numerous studies have indicated that MDMA causes anxiety problems in drug 
users (for review see Baylen et al., 2006), our results revealed that MDMA alone does not 
exert a strong effect on levels of anxiety in adolescent mice. The few studies performed in 
the plus maze with mice have shown that acute MDMA administration induces anxiogenic 
or anxiolytic effects that vary depending on the dose employed (Navarro et al. 2002). 
Although all the available evidence supports an anxiogenic effect of acute cocaine 
administration in adult mice (Erhardt et al., 2006), cocaine did not affect the behaviours 
studied in the plus maze in our study. One possible explanation could be the different 
experimental conditions of the studies compared or a different dose-response curve to 
cocaine in adolescent versus adult mice. These results endorse the hypothesis that 
adolescent animals are more “protected” from adverse psychostimulant-related properties 
than older subjects (Laviola et al., 1999), and highlight the importance of employing 
adolescent animals in studies.  
Another important observation of our study was that an increase in DA turnover in the 
striatum was observed only when both drugs were administered together, due to a 
substantial increase in DOPAC concentration that was not accompanied by alterations of 
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DA levels. Neither serotonin nor its metabolites were altered in the striatum, but there was 
an increase in the concentration of serotonin in the cortex (total cortex, including the frontal 
cortex), which led to a decrease in its turnover. Although MDMA and cocaine act on the 
same neurotransmitter systems, the mechanisms involved differ, as do the effects produced. 
MDMA provokes an acute release of both serotonin and dopamine from nerve terminals 
(review in Colado et al., 2004) and is more potent in inhibiting serotonin and norepinephrine 
than dopamine transporters, while cocaine blocks these three monoamine transporters at 
similar concentrations (Han et al., 2006). One report suggested that serotonin plays a more 
prominent role in the psychotropic effects of MDMA than in those of cocaine (Itzhak et al., 
2006). As in our study, both drugs were administered together, cocaine appeared to block 
MDMA entry into the nerve terminals, thereby inhibiting MDMA-mediated monoamine 
release, which mainly affects serotonin. On the other hand, the reuptake-blocking effects of 
these compounds may have been an added factor that made DA more available to the 
synapse, which could have been responsible for the increase in dopaminergic turnover 
observed. This DA/serotoninergic balance, which occurred only in the groups treated with 
both drugs, could be, in part, responsible for the anxiolytic effect observed when cocaine 
and MDMA were administered together. Our results endorse the hypothesis of Diller and 
coworkers (2007), since we have observed an increase in DA turnover and lower levels of 
serotonin turnover in the striatum and cortex. These findings point to an increase in DA 
availability in conjunction with the release of serotonin in small amounts or at a slow rate, 
leading to a decrease in its turnover. These studies demonstrate that the combined use of 
MDMA and cocaine produces a specific neurochemical and behavioural profile different to 
that observed when each drug is administered alone.  
6.1.2 MDMA plus cannabinoids 
Several studies have highlighted that the prolonged combined use of MDMA and cannabis is 
associated with a variety of psychological problems, including elevated impulsiveness, anxiety 
and psychotic behaviour (Daumann et al., 2004). The cannabinoid system interacts with a 
variety of neurotransmitters, including DA and serotonin (Nakazi et al., 2000), and represents 
a common neurobiological substrate for the addictive properties of different drugs of abuse 
(Maldonado et al., 2006). In line with this, many of the physiological responses provoked by 
MDMA are modulated by the endocannabinoid system (Piomelli et al., 2005). 
Few studies have clarified the effects of exposure to cannabinoids on liability to MDMA 
abuse, and most of them suggest that cannabinoid agonists potentiate the rewarding effects 
of MDMA (Braida & Sala, 2002). However, studies performed recently have demonstrated 
that cannabinoid agonists modify sensitivity to the behavioural effects of MDMA in 
different ways (increase/decrease) depending on the dose employed. We have observed 
that a low dose of the specific CB1 agonist WIN 55212-2 increases the rewarding effects of an 
ineffective dose of MDMA administered during acquisition of the CPP. However, higher 
doses of the cannabinoid agonist weaken the preference induced by effective doses of 
MDMA (Manzanedo et al., 2010). Our results are in accordance with those of Robledo and 
co-workers (2007), who reported that a sub-threshold dose of THC produced CPP in mice 
when combined with a non-rewarding dose of MDMA but decreased the CPP induced by 
an effective dose of MDMA.  
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Cannabinoids participate in the regulation of DA synthesis, release and turnover (Gardner 
et al., 1998). The overlapping expression of cannabinoid and dopamine receptors in some 
brain areas such as the nucleus accumbens (Hermann et al., 2002) may represent a 
neuroanatomical substrate for such an interaction. At doses that neither WIN 55212-2 nor 
MDMA alter brain monamines, animals treated with both drugs exhibited decreases of 
striatal DA and serotonin in the cortex (Manzanedo et al., 2010). Despite the anti-
inflammatory and anti-oxidative properties of cannabinoids (Pazos et al., 2008; Aggarwal et 
al., 2009), animal studies have revealed that chronic administration of THC causes 
hippocampal damage (Fisk et al., 2006) and that exposure to low concentrations of 
cannabinoids over a prolonged period is likely to have a neurotoxic effect (Rubovitch et al., 
2002; Sarne & Keren, 2004). This evidence points to the capacity of cannabinoids to increase 
the neurotoxic potential of MDMA.  We must keep in mind that, due to the crucial role that 
the DA system plays in the reinforcing effects of drugs of abuse, the neurotoxic effect of 
MDMA on mice could modulate the response of lesioned brains to these drugs. For instance, 
mice pre-exposed to neurotoxic doses of MDMA exhibit a higher consumption of, and a 
preference for, EtOH than saline-treated animals (Izco et al. 2007). 
6.2 Binge pattern 
6.2.1 MDMA plus cocaine 
Epidemiological data reveal that the majority of MDMA users cease taking the drug 
spontaneously in their twenties (von Sydow et al., 2002), which highlights the relevance of 
using adolescent subjects in animal models. In addition to presenting a distinctive 
behavioural profile (Spear, 2000; Adriani & Laviola, 2003), young rats and mice are highly 
sensitive to the administration of psychostimulant agents (Laviola et al., 1999; Spear, 2000). 
Both MDMA and cocaine have been proved to induce long-term response after their 
consumption. MDMA users present weeks after discontinuation of intake, a reduced 
hormonal response to drug challenge and a combination of depressive pattern, dysphoria, 
high levels of aggressiveness and elevated scores of novelty-seeking behaviour (Gerra et al., 
1998). These long-term effects have also been described in mice and rats exposed to MDMA 
during adolescence, among which changes in social behaviour (Morley-Fletcher et al., 2002), 
motor activity (Balogh et al., 2004) and anxiety levels (Faria et al., 2006; Clemens et al., 2007) 
have been detected. On the other hand, cocaine administration also induces long-term 
effects in adolescent mice, which are expressed through increased flee and avoidance 
behaviour and fewer social contacts (Estelles et al., 2006). However, the long-lasting effect of 
the combination of two drugs taken during adolescence has received little attention. 
Furthermore, it should be taken into consideration that human MDMA and cocaine 
consumers commonly adhere to a binge pattern, which has been associated with a higher 
occurrence of stimulant-induced psychosis and addiction (Gawin, 1991; Segal & Kuczenski, 
1997; Belin et al., 2011). To explore these effects, we performed a series of studies using a 
model that mimics a binge pattern of MDMA and cocaine consumption. This model consists 
of two daily injections (at 8 am and 8 pm) of an identical dose of MDMA alone or plus 
cocaine, for 3 days (6 administrations), between postnatal day 28 and 30. Mice were 
evaluated three weeks after the last treatment, on postnatal day 51. MDMA administration 
decreased the concentration of striatal DA when administered at high doses (20 mg/kg) in 
agreement with previous reports (for review see Colado et al., 2004), but cocaine inhibited 
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this decrease in DA concentration three weeks later (Daza-Losada et al., 2008a). In 
accordance with these results, pretreatment with the dopamine uptake inhibitor GBR 12909 
prevented long-term loss in the striatal concentration of DA (O'Shea et al., 2001). This lack of 
neurotoxicity could have been due to the effect exerted on body temperature by the two 
drugs together, as cocaine is known to counteract the increase produced by neurotoxic doses 
of MDMA. Most evidence suggests that merely preventing MDMA-induced hyperthermia is 
enough to produce significant neuroprotection (Colado et al., 2001). Although a rise in 
temperature is an important element in MDMA-induced neurotoxicity, this phenomenon 
appears to involve more than MDMA metabolites, including dopamine deamination and/or 
autooxidation (Sprague & Nichols, 2005). As we administered both drugs together, it is also 
feasible that cocaine interfered with the dopamine uptake system by inhibiting the entry of 
MDMA into the nerve terminal. By affecting one or several of these processes, cocaine is 
capable of blocking dopamine neurodegeneration in the mouse brain. 
Since many MDMA users employ opiates in order to relieve the psychostimulant effects of 
ecstasy, it is of relevance to evaluate whether such individuals are subject to an increase in 
the well-known rewarding properties of morphine. We have observed that, following 
MDMA binges during adolescence, sensitivity to reinstatement of an extinguished 
preference is increased, as a morphine-induced preference was reinstated with lower 
priming doses in MDMA–treated mice than in non-treated animals (Daza-Losada et al., 
2008b). In the literature regarding learning, reinstatement refers to the recovery of a learned 
response when a subject is non-contingently exposed to either a conditioned or an 
unconditioned stimulus after extinction. This recovery of a learned response, which 
represents a return to drug seeking, occurs when rats or mice are exposed to drugs, drug 
cues or stressors following extinction. In the CPP version of the reinstatement model, an 
extinguished CPP is robustly reinstated by non-contingent administration of a priming dose 
of the drug (Aguilar et al., 2009). Contrasting results were obtained when adolescent mice 
were treated with cocaine alone or plus MDMA. These animals need higher priming doses 
of morphine than non-treated mice in order to reinstate the preference. The ability of 
repeated treatment with psychomotor stimulants to enhance the response to subsequent 
challenge by an opiate seems to be affected by the route and timing of administration of 
each drug. Prenatal treatment with cocaine decreases the rewarding actions of morphine in 
adult offspring (Estelles et al., 2006), while, in adult rats, doses of morphine that fail to 
produce CPP have been shown to induce a marked preference in those which have 
previously received cocaine (Shippenberg et al., 1998). However, when acute challenge with 
heroin takes place 3 weeks after daily systemic injections of cocaine, locomotor cross-
sensitization does not occur (DeVries et al., 1998). When cocaine is administered during 
gestational development, the development of brain reward systems can be altered, resulting 
in a long-term attenuation of the rewarding properties of morphine. Nevertheless, the 
possibility that such animals are unable to form the necessary association between a 
particular environment and morphine cannot be ruled out (Heyser et al., 1990; Inman-Wood 
et al., 2000). Additionally, prenatal exposure to cocaine can reduce the duration of 
pregnancy, gestational weight gain and food intake in the dams, factors that can contribute 
to an abnormal response to morphine. Finally, an association between prenatal cocaine 
exposure and the effect of altered maternal behaviour on later cognitive functions cannot be 
ruled out.  
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Thus, MDMA-treated mice are more vulnerable to relapse after receiving a priming 
administration of morphine, but this tendency is completely blocked in animals exposed to 
cocaine, in which an opposite effect is exhibited. Cocaine induces modifications in DA 
receptor function and transduction events mainly in the mesocorticolimbic dopamine 
pathway, where it induces an up-regulation of the cAMP-signalling pathway (Nestler, 2004) 
and augments the activity of the transcription factor cAMP response element-binding 
protein (CREB) (Walters et al., 2003). Increased CREB expression in the nucleus accumbens 
undermines the rewarding effects of both cocaine (Carlezon et al., 1998) and morphine 
(Barrot et al., 2002). In addition, repeated exposure to cocaine upregulates DYN/KOPr 
systems (Shippenberg et al., 2007).. This increase may initially serve as a homeostatic 
response that opposes the alteration in neurotransmission that occurs after exposure to this 
drug use. However, following the discontinuation of drug use, the unopposed actions of this 
system are likely to result in dysregulation of basal DA and glutamate transmission, thereby 
contributing to aberrant activity within the prefrontal-cortico-striatal loop (Shippenberg et 
al., 2007). These could represent some of the mechanisms responsible for the way in which 
cocaine affects the response of the dopaminergic system by altering the intensity of the 
response to priming.  
MDMA and cocaine are often first consumed at an early age, and the response to MDMA of 
users in their twenties can be affected by previous exposure to these or other drugs. 
Similarly to the observations reported with morphine, Achat-Mendes and co-workers (2003) 
found that a priming injection of cocaine after extinction reinstated a significantly higher 
CPP in mice previously exposed during adolescence to a comparable regimen of MDMA. 
Comparable results have been described in adolescent (Aberg et al., 2007) and adult rats 
(Horan et al., 2000). These results are also in accordance with the finding that the acquisition 
of cocaine self-administration is facilitated in rats pre-exposed to MDMA (Fletcher et al., 
2001). Concurring with these results, we have demonstrated that exposure to MDMA or 
cocaine binges during adolescence induces long-lasting changes that increase the reinforcing 
effects of MDMA (Daza-Losada et al., 2009b). We observed that only mice previously 
exposed to MDMA developed CPP after being conditioned with a sub-threshold dose of 
MDMA. On the other hand, although all the groups developed CPP after conditioning with 
10 mg/kg of MDMA, the extinguished preference was reinstated only in animals exposed to 
MDMA or cocaine during adolescence, in which it also took longer for the preference to be 
extinguished. Extinction provides a measurement of the motivational properties of drugs, 
which are evident in the persistence of drug-seeking behaviour in the absence of the drug 
(Aguilar et al., 2009). This is a powerful means of assessing the incentive motivational 
properties of drug-paired stimuli or non-contingent drug administration in the reinstating 
response (Pulvirenti, 2003). However, when the two drugs were administered together, 
cocaine blocked the increases that MDMA induced in sensitivity to the MDMA-induced 
CPP and in vulnerability to reinstatement of the preference. Once again, as the two drugs 
were administered simultaneously, the competition for the same molecular target could 
have affected their action, leading to a weaker effect.  
Most authors believe that increases in drug-induced CPP or self-administration observed in 
animals exposed to MDMA are due to the actions that MDMA exerts on the serotoninergic 
system (Horan et al. 2000; Fletcher et al. 2001). However, in many cases, it has been reported 
that the MDMA regimen employed did not induce dopaminergic or serotoninergic 
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neurotoxicity, which was indeed the case in the studies mentioned above. None of the 
drugs, whether administered alone or together, induced significant changes in the 
concentration of these monoamines in the striatum, cortex or hippocampus 3 weeks later, at 
which time CPP was initiated (Daza-Losada et al. 2008b). Moreover, the chosen CPP 
schedule did not affect the concentration of monoamines (Daza-Losada et al. 2007). 
 
Fig. 2. Effects of MDMA or cocaine administration during adolescence on the acquisition 
and reinstatement of morphine or MDMA-induced CPP in adult mice. Bars represent mean 
(±SEM) time spent in the drug-paired compartment before conditioning session (□), after 
conditioning session (■), in the last extinction session (light grey), and in the reinstatement 
test (dark grey). During adolescence, mice were treated with six injections of physiological 
saline, 10 mg/kg of MDMA, or 25 mg/kg of cocaine. Three weeks later mice were 
conditioned with 40 mg/kg of morphine, or 10 mg/kg or 1.25 mg/kg of MDMA. After 
conditioning and extinction procedures, all animals received a priming injection of 50% of 
the drug dose administered during conditioning. In the subsequent reinstatement test, the 
priming doses employed were 25 and 12.5% that used during conditioning. MDMA 
exposure during adolescence increased the vulnerability to reinstatement of the 
extinguished preference induced by morphine and MDMA. This effect was also induced by 
administration of cocaine during adolescence. Pre-treatment with MDMA also increased its 
rewarding effects. * p< 0,05, **p<0.01, ***p<0.001 significant difference in time spent in Post-
C or Reinstatement tests vs. Pre-C session. Modified from Daza-Losada et al 2008b, 2009b). 
6.2.2 MDMA and ethanol binges 
Another drug often taken by adolescents in combination with ecstasy is alcohol (Riley et al., 
2001; Barrett et al., 2006). Physiological and behavioural studies in humans and rodents have 
demonstrated an interaction between these two drugs (Mohamed et al., 2009). In humans, 
ethanol enhances and prolongs the euphoria and feelings of well-being induced by MDMA 
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(Hernández-López et al., 2002), but moderates some of its physiological effects, such as fluid 
retention and hyperthermia (Dumont et al., 2010). In addition, animal models have 
demonstrated that the hyperpyretic effect of MDMA is modulated by Ethanol according to 
the moment of ethanol administration and ambient temperature (Cassel et al., 2004, 2005 
and 2007). 
Research has only recently begun to use animal models to evaluate ethanol–MDMA 
interactions. Ethanol was shown to increase MDMA concentrations not only in blood but 
also, and to a greater extent, in the striatum and cortex than in the hippocampus (Hamida et 
al. 2009). On the other hand, levels of alcohol dehydrogenase 2, which metabolizes ethanol 
to acetaldehyde, were found to be 35% lower in MDMA-treated rats than in controls (Upreti 
et al. 2009). EthOH significantly potentiates the MDMA-induced outflow of serotonin and 
DA in rat striatal slices (Riegert et al., 2008). EthOH also affects the neurotoxicity induced by 
MDMA, although discrepant results have been reported. In rats, EtOH treatment before 
MDMA administration enhances long-term neurotoxicity, while in mice, EtOH protects DA 
neurons from the toxic effects of MDMA when evaluated 72 h after the first injection 
(Johnson et al., 2004). At the behavioural level, EtOH administration potentiates MDMA-
induced hyperlocomotion in rats (Cassel, et al. 2004; Riegert, et al. 2008), and repeated co-
administration of the two drugs results in a pronounced sensitization of hyperactivity 
(Hamida et al., 2007, 2008). Recently, Jones and co-workers (2010) have reported CPP in rats 
that received MDMA plus ethOH but not in those administered just with one of these drugs. 
These results suggest that acute co-administration of EtOH plus MDMA potentiates the 
reinforcing effects of each drug alone. Moreover, administration of EtOH would appear to 
increase the risk of compulsive use of MDMA.  
A small number of studies have evaluated chronic exposure to both ethOH and MDMA, 
and none have explored this interaction in adolescent animals. Employing a model of binge 
drinking in which animals are treated during adolescence with intermittent doses of ethOH 
(a total of 16 doses administered intraperitoneally; two per day for two days, followed by a 
two-day interval without drugs), we aimed to imitate the pattern of weekend binge drinking 
that is currently so common among adolescents.  
Mice were injected twice per day on postnatal day 29, 30, 33, 34, 37, 38, 41, and 42 and with 
MDMA twice daily on postnatal day 33, 34, 41, and 42. The behavioural and neurochemical 
test took place three weeks after the last drug administration. Pascual and co-workers (2007) 
demonstrated that this pattern of ethOH administration during adolescence enhances neural 
cell death in several brain regions (neocortex, hippocampus, and cerebellum) and induces 
long-lasting neurobehavioural impairments in conditional discrimination learning as well as 
motor learning and discrimination between novel and familiar objects. We too have 
observed that exposure to ethOH during adolescence increases the anxiogenic response 
induced by MDMA in the elevated plus maze, with adult treated-mice spending less time in 
the open arms of the maze than non treated littermates. In addition, although ethOH 
undermines the hyperthermic response induced by MDMA, animals exposed to ethOH plus 
MDMA exhibit lower concentrations of DA in the striatum than those treated with MDMA 
only (Rodriguez-Arias et al., 2011). In the study in question, though ethanol efficiently 
decreased the hyperthermic response induced by MDMA, it did not protect mice treated 
with 20 mg/kg of MDMA and actually increased the toxic effect in those treated with 10 
mg/kg of MDMA, in which a hypothermic response was observed. This effect could be the 
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result of binge pattern ethOH administration enhancing MDMA-induced long-term 
neurotoxicity through a mechanism that is unrelated to changes in acute hyperthermia and 
which is thought to involve hydroxyl radical formation (Izco et al., 2007). All the groups that 
presented reduced levels of striatal DA exhibited increased levels of anxiety. We have 
previously observed that adolescent mice treated with a schedule of MDMA that provoked 
a similar decrease in DA concentration without alterations in DOPAC levels behave 
normally in the elevated plus maze (Daza-Losada et al. 2008b). However, in our study, the 
decrease in DA was accompanied by a considerable decrease in DOPAC levels, which may 
have been responsible for the behavioural differences observed. Dopamine plays an 
important role in anxiety by modulating a cortical brake that the medial prefrontal cortex 
exerts on the anxiogenic output of the amygdala. It also has a considerable influence on the 
trafficking of impulses between the basolateral and central nuclei of the amygdala. Intra-
amygdaloid infusion of D1 agonists and antagonists elicits anxiogenic and anxiolytic effects, 
respectively, suggesting an anxiogenic role for D1 receptors in the amygdala. Analyses of 
the effects of D2 agonists and antagonists suggest that, depending on the model of anxiety 
in question, either anxiogenic or anxiolytic effects are elicited (de la Mora et al., 2010). 
 
Fig. 3. Effects of MDMA, cocaine or ethanol binge administration during adolescence on the 
striatal DA concentration three weeks after the last drug administration. Co-administration of 
cocaine counteracted the neurotoxic effect of binge administration of 20 mg/kg of MDMA. 
However, intermittent ethanol administration increased the dopaminergic decrease induced 
by a non-neurotoxic dose (10 mg/kg) of MDMA.  *** p<0.001 differences with respect to the 
saline group. Modified from Daza-Losada et al 2008a, and Rodriguez-Arias et al., 2011. 
In addition to inducing long-term consequences for the rewarding effects of drugs, any 
manipulation or intervention during adolescence can produce other changes, such as the 
reactivity of the HPA axis to different stressful situations. In a series of recent reports 
(Ribeiro do Couto et al., 2011a, 2011b), we observed that exposure during adolescence to 
intermittent injections of ethOH or MDMA modify the response of mice to MDMA 
administration in adulthood, in addition to previous reports that pointed out long-term 
behavioural (an increase in anxiety) and neurochemical (a rise in MDMA-induced 
neurotoxicity) effects (Rodriguez-Arias et al., 2011). Pre-exposure to ethOH, MDMA or both 
increased the rewarding effects of an ineffective dose of MDMA (1.25 mg/kg). Although 
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these pre-treatments did not affect acquisition of the CPP induced by higher doses, the 
preference was more persistent in mice pre-exposed to MDMA, ethOH or to both drugs. In 
addition, reinstatement of the extinguished preference was achieved with lower priming 
doses of MDMA in the groups pre-exposed to ethOH or MDMA (Ribeiro do Couto et al., 
2011a). These effects appear to be due to the changes in the rewarding effects of MDMA 
rather than unspecific effects such as changes in basal motor activity or stress levels. After 
conditioning adults mice with an effective (but non neurotoxic) dose of MDMA (10 mg/kg), 
we once again observed that MDMA or ethanol exposure during adolescence increased the 
time required to extinguish the preference induced by MDMA and that these effects were 
related with an increase in either brain monoamine or corticosterone levels in response to 
MDMA (Ribeiro do Couto et al., 2011b). Mice treated with ethanol after the priming 
injection presented a significant increase in striatal DA. It is possible that this stronger 
neurochemical response to the priming dose of MDMA increased the efficacy of 
conditioning, reflected in a greater resistance to extinction. Similarly, the administration of 
10 mg/kg of MDMA led to higher corticosterone values in mice exposed to MDMA during 
adolescence, while the response to low-mild stressors or to 5 mg/kg of MDMA did not 
differ, which could produce a stronger learning during conditioning. 
In these series of studies, the combination of intermittent administration of ethOH+MDMA 
did not produce synergistic effects at either behavioural or neurochemical levels. In fact, the 
combination of the two drugs would seem to counteract the behavioural and hormonal 
effects of MDMA observed when each is administered alone. These results are in line with 
the previously discussed observation that adolescent exposure to MDMA exerts more 
powerful and longer-lasting effects on an MDMA-induced CPP than exposure to 
cocaine+MDMA (Daza-Losada et al., 2009). In this case, it is possible that ethanol interferes 
with the metabolism of MDMA and with its penetration of, and/or elimination, from the 
brain, and that this is responsible for the lack of effects observed after co-administration. 
Evidence that ethanol increases brain and blood concentrations of MDMA (Johnson et al., 
2004) implies an enhanced MDMA-based neurotoxicity and an increased liability to abuse 
(Hamida et al., 2009). Since no neurotoxic effects were observed after any of the drug pre-
treatments measured in the first reinstatement test, our results could be explained by the 
fact that ethanol increases the concentration of MDMA in the brain. Indeed, we found that 
the rewarding effects of MDMA produced an inverted U-curve in function of dose, with 
high doses proving to be devoid of motivational effects (Daza-Losada et al., 2007). 
6.3 Cross-reinstatement and sensitization studies 
This last section is dedicated to other kinds of drug interaction, cross-reinstatement and 
sensitization phenomena. Cross-reinstatement can be defined as the reinstatement of 
extinguished drug-seeking by drugs other than the previously self-administered or 
conditioning drug. This phenomenon has been widely demonstrated in self-administration 
and CPP studies. Cross-reinstatement with drugs from different classes to that of the self-
administered drug has been demonstrated using the self-administration model. 
Cannabinoid agonists, DA agonists and re-uptake inhibitors and morphine, among others, 
produce reinstatement of cocaine-seeking after self-administration of cocaine has ended 
(reviewed by Shalev et al., 2002). Similarly, amphetamine and cocaine produce 
reinstatement of heroin self-administration (De Vries et al., 1998). Some studies have also 
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demonstrated cross-reinstatement using the CPP paradigm. An extinguished cocaine-
induced CPP can be reinstated by a priming injection of related psychostimulants (Itzhak & 
Martin, 2002), and of other drugs of abuse of different pharmacological classes (Romieu et 
al., 2004). In the same way, we observed that a cocaine or amphetamine priming following 
extinction reinstated morphine-induced CPP (Ribeiro Do Couto et al., 2005). In a series of 
recent studies, we have also observed cross-reinstatement between cannabinoids and 
MDMA in adolescent animals. Extinguished MDMA-induced CPP was reinstated after a 
priming injection of the CB1 cannabinoid agonist WIN 55212-2, but this phenomenon only 
occurred in animals exposed to the cannabinoid agonist during adolescence (Rodríguez-
Arias et al., 2010). However, in mice conditioned with WIN 55212-2, a priming injection of 
MDMA was capable of reinstating the extinguished preference without pre-exposure 
(Manzanedo et al., 2010). Most authors agree that the mesocorticolimbic DA system is 
involved in cross-reinstatement. For instance, Wang et al. (2000) suggested that opiates and 
psychostimulants can all activate the mesolimbic DA system to release DA, which is a 
mechanism underlying the relapse to drug-seeking behaviour induced by morphine, cocaine 
or amphetamine. It is possible that one drug cross-primes the other via this common 
pathway, which is involved in incentive motivation and appetitive goal-directed behaviour 
(Wang et al., 2000). Such evidence of cross-reinstatement between drugs of different 
pharmacological classes has also been found in adolescents and suggests that, in drug-
abstinent individuals, exposure to an addictive drug can produce intense craving for the 
previously abused drug and thus lead to relapse to drug-taking and dependence.  
The repeated, intermittent administration of a variety of potentially addictive drugs 
produces persistent increases in their incentive motivational properties (Manzanedo et al., 
2004, 2005; Shippenberg & Heidbreder, 1995). Age-related differences in psychostimulant 
sensitization profiles have been described (Laviola et al., 1995, 1999), with adolescent rats 
proving to be less vulnerable to MDMA-induced sensitization, only developing this 
response to MDMA when administered with a high dose and within a narrow margin of 
time (Aberg et al., 2007). In a recent study, we have evaluated for the first time the effect of 
adolescent exposure to cannabinoids on the reinforcing effects of MDMA (Rodriguez-Arias 
et al., 2010). On postnatal day 27, animals received the first of five daily injections of the 
cannabinoid agonist WIN55212-2, and three days later the place conditioning procedure for 
MDMA was initiated. In mice pre-exposed to cannabinoids, sub-threshold doses of MDMA 
induced CPP and reinstatement of an extinguished preference. In the same way, delta-9-
tetrahydrocannabinol administration increased hedonic reactions to sucrose and the rise of 
dialysate DA in the shell of the NAc (de Luca et al., in press). These results endorse the 
gateway hypothesis, which is sustained by numerous epidemiological studies and suggests 
that prior exposure to cannabinoids encourages use of other illicit drugs such as 
psychostimulants (Lynskey et al., 2003). Few studies have tested this hypothesis in animal 
models, and those that have done so do not provide firm support for it. However, the 
adolescent brain is particularly sensitive to external and internal variables such as drug 
exposure, since this phase of development is characterized by active neural changes in, for 
example, synapse formation and elimination, in brain areas essential for behavioural and 
cognitive functions (Charmandari et al., 2003; Rice & Barone, 2000). Consequently, exposure 
to cannabis during the adolescent period may increase vulnerability to subsequent drug 
abuse disorders. 
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Authors Treatment employed Specie Age
Behaviour studied/
model employed
Drugs of abuse Results
 Diller et al 2007 acute treatment rats adult MDMA- or cocaine-
induced CPP
MDMA and cocaine
Both drugs induced CPP when 
administered alone. Co-administration 
produced an antagonism, except at high 
doses 
Daza-Losada et al., 2009a acute treatment mice adolescent
Anxiety (EPM) and 
striatal monoamine levels MDMA and cocaine
Anxiolytic response in the elevated plus 
maze  and increased DA turnover in the 
striatum  only when the two drugs were 
administered together




Cannabinoid agonists potentiated the 
rewarding effects of MDMA 
Manzanedo et al., 2010 acute treatment mice adolescent MDMA- induced CPP MDMA and 
cannabinoid agonist
Low dose of the  CB1 agonist increased the 
rewarding effects of an ineffective dose of 
MDMA, but higher doses of the 
cannabinoid agonist weakened the 
preference induced by effective doses of 
MDMA 
Robledo et al (2007) acute treatment mice adult THC-induced CPP ∆9-THC and MDMA 
A sub-threshold dose of THC produced CPP 
in mice when combined with a non-
rewarding dose of MDMA, but decreased 
the CPP induced by an effective dose of 
MDMA
Daza-Losada et al., 2008a
MDMA and cocaine binge 
during adolescence mice adolescent Striatal monoamine levels  MDMA and cocaine
MDMA-induced long-lasting decreases in 
the concentration of striatal DA at high 
doses, but cocaine inhibited this effect 
Daza-Losada et al., 2008b
MDMA binge during 
adolescence mice adolescent Morphine-induced CPP MDMA and morphine
Sensitivity to reinstatement of an 
extinguished preference was increased in 
morphine-induced CPP
Estelles et al., 2006
Prenatal cocaine 
administration mice adult Morphine-induced CPP Cocaine and morphine
Prenatal treatment with cocaine decreased 
the rewarding actions of morphine in adult 
offspring 
Achat-Mendes et al., 2003
MDMA binge during 
adolescence
mice adolescent Cocaine-induced CPP Cocaine and MDMA
A priming injection of cocaine after 
extinction reinstated a significantly higher 
CPP in mice previously exposed to MDMA 
during adolescence
Daza-Losada et al., 2009b
MDMA and cocaine binge 
during adolescence
mice adolescent MDMA- induced CPP Cocaine and MDMA
Only mice previously exposed to MDMA 
developed CPP after conditioning with a 
sub-threshold dose of MDMA. The 
extinguished preference was reinstated only 
in animals exposed to MDMA or cocaine 
during adolescence
Jones et al (2010) acute treatment rats adult
MDMA- and EtOH- 
induced CPP MDMA and EtOH
CPP was detected in rats that had received 
MDMA plus ethanol but not in those that 
had been administered just one of the drugs
Rodriguez-Arias et al., 2011
MDMA and EtOH binge 
during adolescence
mice adolescent Anxiety (EPM) and 
striatal monoamine levels
MDMA and EtOH
An increase was observed in the anxiogenic 
response induced by MDMA in adult mice 
treated with MDMA plus EtOH. EtOH 
increased the neurotoxic effect of MDMA
Ribeiro do Couto et al., 2011a, 2011b
MDMA and EtOH binge 
during adolescence mice adolescent MDMA-induced CPP MDMA and EtOH
Pre-exposure to EtOH, MDMA or both 
drugs increased the rewarding effects of an 
ineffective dose of MDMA. Reinstatement 
of the extinguished preference was achieved 
with lower priming doses of MDMA in the 
groups pre-exposed to ethanol or MDMA  
Table 1. Synthesis of the most relevant interactions observed in the different models 
explained within the text.  
7. Conclusion 
In conclusion, the risks associated with multi-drug exposure during adolescence are still 
unclear. The high frequency of the combined used of several drugs in human adolescent 
users demands an in-depth evaluation of their interaction. It is obvious that the developing 
brain is highly vulnerable to the damaging effects of drugs; effects that can be irreversible. 
Studies performed to date demonstrate that the combined use of drugs produces a specific 
neurochemical and behavioural profile which differs to that observed when each drug is 
administered alone. These kinds of studies are more complicated to perform than those 
employing only one drug and involve many more variables that need to be controlled. 
Nevertheless, despite their complexity and the limitations inherent in their design, each of 
these studies constitutes a piece of a giant jigsaw puzzle which, as it is gradually put 
together, provides an increasingly clearer image of the reality of drug use. 
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